Your browser doesn't support javascript.
loading
Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells.
Baranowska, Katarzyna; Misund, Kristine; Starheim, Kristian K; Holien, Toril; Johansson, Ida; Darvekar, Sagar; Buene, Glenn; Waage, Anders; Bjørkøy, Geir; Sundan, Anders.
Afiliación
  • Baranowska K; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Misund K; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Starheim KK; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Holien T; CEMIR-Center of Molecular Inflammation Research, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Johansson I; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Darvekar S; CEMIR-Center of Molecular Inflammation Research, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Buene G; Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Waage A; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Bjørkøy G; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Sundan A; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Oncotarget ; 7(43): 70845-70856, 2016 Oct 25.
Article en En | MEDLINE | ID: mdl-27683126
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Antineoplásicos / Inhibidores Enzimáticos / Hidroxicloroquina / Mieloma Múltiple Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Antineoplásicos / Inhibidores Enzimáticos / Hidroxicloroquina / Mieloma Múltiple Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos